STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through the PI3K/Akt/mTOR pathway-mediated autophagy induction

The pathogenesis exploration and timely intervention of hepatocellular carcinoma (HCC) are crucial due to its global impact on human health. As a general tumor biomarker, stanniocalcin 2 (STC2), its role in HCC remains unclear. We aimed to analyze the effect and mechanism of STC2 on HCC.